00:00 Speaker A It’s time for Yahoo Finance’s market minute. US stocks start the week with a volatile trading session. Wall Street continuing to assess AI jitters that have hammered markets in recent weeks, Read More
Tags :Josh Lipton
00:00 Speaker A Google’s new AI tool Project Genie is sparking a sharp selloff in gaming stocks as investors now weigh how disruptive this really could be for the industry. 00:10 Speaker A And Unity, one Read More
00:00 Josh Well, Google turning heads in the video game world with the launch of Project Genie and rattling some major gaming stocks in the process. Joining me now, we got Yahoo Finance Tech editor, Dan Read More
00:00 Speaker A You’re upgrading your view on Open AI and its orbit. In plain English, explain why Gil and why public market investors who are listening right now, Gil, why should they care? 00:16 Gil Read More
00:00 Josh Dan, how about Google Cloud? Revenue 17.66 billion. Uh, that looks better than consensus. How do you see, what what are the trends in that business, Dan, in the year ahead? 00:08 Dan Josh, I think Read More
00:00 Josh We’re joined here now is Ivanka Delska, founder and CIO at Spear Invest and Dan Flax, Newburger Burman senior research analyst. 00:08 Josh Welcome to you both. I’ll start with you. Um, the Read More
00:00 Speaker A Microsoft, Meta and and Apple put forth a mixed bag of results for investors, but Wall Street sending a strong message to tech giants that pressure is on to prove spending can power Read More
00:05 Speaker A Time now for what to watch Wednesday, February 4th. We’re going to start off on the earnings front. Multiple big names on deck Wednesday including Uber and Qualcomm, but all eyes on Read More
00:00 Speaker A Another big theme, Allie, heading into these reports is going to be cloud growth. Uh I’m just curious, you know, Amazon, Microsoft, Google broadly. What kind of cloud growth are you looking Read More
00:02 Speaker A Time now for what to watch. It’s going to be a busy earning stretch ahead with big tech firmly in focus. 00:07 Speaker A We’re also going to hear from major pharma Read More